
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.".
Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.".
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals